BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

632 related articles for article (PubMed ID: 29987329)

  • 1. Effect of Infusion of Calcitonin Gene-Related Peptide on Cluster Headache Attacks: A Randomized Clinical Trial.
    Vollesen ALH; Snoer A; Beske RP; Guo S; Hoffmann J; Jensen RH; Ashina M
    JAMA Neurol; 2018 Oct; 75(10):1187-1197. PubMed ID: 29987329
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sumatriptan Does Not Antagonize CGRP-Induced Symptoms in Healthy Volunteers.
    Falkenberg K; Rønde Bjerg H; Yamani N; Olesen J
    Headache; 2020 Apr; 60(4):665-676. PubMed ID: 31944310
    [TBL] [Abstract][Full Text] [Related]  

  • 3. S100B and NSE in Cluster Headache - Evidence for Glial Cell Activation?
    Snoer AH; Vollesen ALH; Beske RP; Guo S; Hoffmann J; Jørgensen NR; Martinussen T; Ashina M; Jensen RH
    Headache; 2020 Sep; 60(8):1569-1580. PubMed ID: 32548854
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Calcitonin-gene related peptide and disease activity in cluster headache.
    Snoer A; Vollesen ALH; Beske RP; Guo S; Hoffmann J; Fahrenkrug J; Jørgensen NR; Martinussen T; Jensen RH; Ashina M
    Cephalalgia; 2019 Apr; 39(5):575-584. PubMed ID: 30854880
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Migraine induction with calcitonin gene-related peptide in patients from erenumab trials.
    Christensen CE; Younis S; Deen M; Khan S; Ghanizada H; Ashina M
    J Headache Pain; 2018 Nov; 19(1):105. PubMed ID: 30409109
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of Vasoactive Intestinal Polypeptide on Development of Migraine Headaches: A Randomized Clinical Trial.
    Pellesi L; Al-Karagholi MA; De Icco R; Coskun H; Elbahi FA; Lopez-Lopez C; Snellman J; Hannibal J; Amin FM; Ashina M
    JAMA Netw Open; 2021 Aug; 4(8):e2118543. PubMed ID: 34357396
    [TBL] [Abstract][Full Text] [Related]  

  • 7. PACAP38- and VIP-induced cluster headache attacks are not associated with changes of plasma CGRP or markers of mast cell activation.
    Pellesi L; Chaudhry BA; Vollesen ALH; Snoer AH; Baumann K; Skov PS; Jensen RH; Ashina M
    Cephalalgia; 2022 Jul; 42(8):687-695. PubMed ID: 34822741
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hypersensitivity to Calcitonin Gene-Related Peptide in Post-Traumatic Headache.
    Ashina H; Iljazi A; Al-Khazali HM; Christensen CE; Amin FM; Ashina M; Schytz HW
    Ann Neurol; 2020 Dec; 88(6):1220-1228. PubMed ID: 32959458
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Safety, tolerability, and efficacy of TEV-48125 for preventive treatment of high-frequency episodic migraine: a multicentre, randomised, double-blind, placebo-controlled, phase 2b study.
    Bigal ME; Dodick DW; Rapoport AM; Silberstein SD; Ma Y; Yang R; Loupe PS; Burstein R; Newman LC; Lipton RB
    Lancet Neurol; 2015 Nov; 14(11):1081-90. PubMed ID: 26432182
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of pituitary adenylate cyclase-activating peptide-38 and vasoactive intestinal peptide in cluster headache.
    Vollesen ALH; Snoer A; Chaudhry B; Petersen AS; Hagedorn A; Hoffmann J; Jensen RH; Ashina M
    Cephalalgia; 2020 Nov; 40(13):1474-1488. PubMed ID: 32962406
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of Different Doses of Galcanezumab vs Placebo for Episodic Migraine Prevention: A Randomized Clinical Trial.
    Skljarevski V; Oakes TM; Zhang Q; Ferguson MB; Martinez J; Camporeale A; Johnson KW; Shan Q; Carter J; Schacht A; Goadsby PJ; Dodick DW
    JAMA Neurol; 2018 Feb; 75(2):187-193. PubMed ID: 29255900
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Two-Hour CGRP Infusion Causes Gastrointestinal Hyperactivity: Possible Relevance for CGRP Antibody Treatment.
    Falkenberg K; Bjerg HR; Olesen J
    Headache; 2020 May; 60(5):929-937. PubMed ID: 32227602
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Effect of Beginning Treatment With Fremanezumab on Headache and Associated Symptoms in the Randomized Phase 2 Study of High Frequency Episodic Migraine: Post-Hoc Analyses on the First 3 Weeks of Treatment.
    Silberstein SD; Rapoport AM; Loupe PS; Aycardi E; McDonald M; Yang R; Bigal ME
    Headache; 2019 Mar; 59(3):383-393. PubMed ID: 30450545
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Suboccipital steroid injections for transitional treatment of patients with more than two cluster headache attacks per day: a randomised, double-blind, placebo-controlled trial.
    Leroux E; Valade D; Taifas I; Vicaut E; Chagnon M; Roos C; Ducros A
    Lancet Neurol; 2011 Oct; 10(10):891-7. PubMed ID: 21903477
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of Fremanezumab Compared With Placebo for Prevention of Episodic Migraine: A Randomized Clinical Trial.
    Dodick DW; Silberstein SD; Bigal ME; Yeung PP; Goadsby PJ; Blankenbiller T; Grozinski-Wolff M; Yang R; Ma Y; Aycardi E
    JAMA; 2018 May; 319(19):1999-2008. PubMed ID: 29800211
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hyperbaric oxygen treatment of active cluster headache: a double-blind placebo-controlled cross-over study.
    Nilsson Remahl AI; Ansjön R; Lind F; Waldenlind E
    Cephalalgia; 2002 Nov; 22(9):730-9. PubMed ID: 12421159
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effects of vitamin D supplementation on interictal serum levels of calcitonin gene-related peptide (CGRP) in episodic migraine patients: post hoc analysis of a randomized double-blind placebo-controlled trial.
    Ghorbani Z; Rafiee P; Fotouhi A; Haghighi S; Rasekh Magham R; Ahmadi ZS; Djalali M; Zareei M; Razeghi Jahromi S; Shahemi S; Mahmoudi M; Togha M
    J Headache Pain; 2020 Feb; 21(1):22. PubMed ID: 32093657
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hypersensitivity to calcitonin gene-related peptide in chronic migraine.
    Iljazi A; Ashina H; Zhuang ZA; Lopez Lopez C; Snellman J; Ashina M; Schytz HW
    Cephalalgia; 2021 May; 41(6):701-710. PubMed ID: 33322922
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Trial of Galcanezumab in Prevention of Episodic Cluster Headache.
    Goadsby PJ; Dodick DW; Leone M; Bardos JN; Oakes TM; Millen BA; Zhou C; Dowsett SA; Aurora SK; Ahn AH; Yang JY; Conley RR; Martinez JM
    N Engl J Med; 2019 Jul; 381(2):132-141. PubMed ID: 31291515
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comprehensive clinical phenotyping of nitroglycerin infusion induced cluster headache attacks.
    Wei DY; Goadsby PJ
    Cephalalgia; 2021 Jul; 41(8):913-933. PubMed ID: 33615843
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 32.